I have BRCA2 germline mutation, Initial diagnosis 2015: Gleason 9, T3bN1M0, Aggressive disease. PSA 10.
December 2020: PSA 600, T4 with extensive bone Mets.
January 2021: Started ADT for the first time, Lupron, then switched to Orgovyx. At same time started adjunct treatment with investigational drug: 3Bromo pyruvate (Dr. Young Ko’s KAT formulation)
January 2022: One year out PSA is stable at 1.0, bone scans much improved, still hormone sensitive… Have not added Zytiga yet, refused Docetaxel .
Interested in other folks experience with BRCA2 Germline mutation+ Aggressive disease and Time from Start of First line hormone deprivation therapy to resistance or Progression